Eszopiclone 1mg, 2 mg, 3 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 1mg, 2 mg, 3 mg

Reference Brands: Lunesta (USA)

Category: Sleep Disorders

Eszopiclone tablets (1, 2 and 3 mg) are a 'Z-drug' sleeping medicine for insomnia, helping both falling and staying asleep. It is the active S-enantiomer of zopiclone. The original brand is Lunesta. It is a controlled medicine in most countries, so we check the buyer's import permits before quoting.

Product Description:

Eszopiclone is a non-benzodiazepine hypnotic medication used for the treatment of both short-term and long-term insomnia. It is marketed under the brand name Lunesta and is taken orally. Unlike many sleep medications, eszopiclone is one of the few FDA-approved hypnotics classified as a controlled substance without strict limitations on duration of use. Clinical evidence supports its effectiveness for up to six months, with some studies indicating sustained efficacy for as long as twelve months, making it suitable for ongoing insomnia management under medical supervision.

Eszopiclone works by enhancing the natural activity of gamma-aminobutyric acid (GABA) in the central nervous system. It acts as a positive allosteric modulator at GABA-A receptors, increasing the frequency of chloride channel opening in the presence of GABA. This mechanism promotes neuronal inhibition, helping to induce and maintain sleep. Importantly, eszopiclone does not force sedation or function as a tranquilizer. Instead, it supports a more natural sleep-wake cycle by facilitating the brain’s normal sleep processes. Due to its targeted action and favorable efficacy profile, eszopiclone is widely used in the management of chronic and transient insomnia.

Controlled medicine — licensed supply only

This product is controlled in many countries under narcotic, psychotropic, precursor or other drug laws, which vary by country. We supply only licensed buyers holding any import certificate, permit or authorisation their national authority requires, and the Indian manufacturer or exporter must hold the required licences. In India, each export of a narcotic drug or psychotropic substance needs an export authorisation, and export of ephedrine, pseudoephedrine or their preparations a No Objection Certificate, from the Narcotics Commissioner (Central Bureau of Narcotics). We verify permits before quoting.